BioCancell Therapeutics, Inc. has developed a Patient-Oriented, Targeted Therapy for diagnosis and treatment of many types of cancer.

Patient-Oriented means only those diagnosed with H19, a gene present in tumors of most cancer patients, are eligible for treatment. Targeted Therapy means the H19 gene drives the synthesis of a toxin only inside the cancer cells, effectively destroying them without damage to surrounding tissue or body systems.

Safe, highly-targeted, effective and usable long-term - it's a break-through!